Involvement of central α1-adrenoceptors on renal responses to central moxonidine and α-methylnoradrenaline

European Journal of Pharmacology

Volumn 607, Issue 1-3, 2009, Pages 60-67

  de Andrade, Carina A F ^a   de Andrade, Glaucia M F ^a   De Paula, Patricia M ^a   De Luca Jr , Laurival A ^a   Menani, José V ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Adrenoceptor Renal excretion; Prazosin; Sodium excretion; Urinary excretion

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 1 ADRENERGIC RECEPTOR; CORBADRINE; MOXONIDINE; PHENYLEPHRINE; PLASMA PROTEIN; POTASSIUM; PRAZOSIN; SODIUM; YOHIMBINE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; IMIDAZOLE DERIVATIVE; IMIDAZOLINE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIURESIS; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; HEMATOCRIT; KALIURESIS; LATERAL BRAIN VENTRICLE; MALE; NATRIURESIS; NONHUMAN; PLASMA OSMOLALITY; POTASSIUM EXCRETION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SODIUM EXCRETION; SPRAGUE DAWLEY RAT; URINARY EXCRETION; URINE VOLUME; WATER LOADING; ANIMAL; DOSE RESPONSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; URINE;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; DIURESIS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIDAZOLES; IMIDAZOLINE RECEPTORS; INJECTIONS, INTRAVENTRICULAR; MALE; NATRIURESIS; NORDEFRIN; PHENYLEPHRINE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; SODIUM;

EID: 62149114809     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.01.039     Document Type: Article

References (33)

1. 2-adrenergic receptors in the antidipsogenic response to moxonidine. Ann. N. Y. Acad. Sci. 1009 (2003) 262-264
2. Bastos R., Favaretto A.L.V., Gutkowska J., McCann S.M., and Antunes-Rodrigues J. Alpha-adrenergic agonists inhibit the dipsogenic effect of angiotensin II by their stimulation of atrial natriuretic peptide release. Brain Res. 895 (2001) 80-88
3. Callera J.C., Camargo L.A.A., De Luca Jr. L.A., Menani J.V., Renzi A., and Saad W.A. Clonidine and phenylephrine injected into the lateral preoptic area reduce water intake in dehydrated rats. Pharmacol. Biochem. Behav. 46 (1993) 39-43
4. De Bold A.J., Borenstein H.B., Veress A.T., and Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28 (1981) 89-94
5. 2-adrenoceptors. Braz. J. Med. Biol. Res. 30 (1997) 497-502
6. De Oliveira L.B., De Luca Jr. L.A., and Menani J.V. Moxonidine and central a2 adrenergic receptors in sodium intake. Brain Res. 993 (2003) 177-182
7. De Paula P.M., Sato M.A., Menani J.V., and De Luca Jr. L.A. Effects of central α-adrenergic agonists on hormone-induced 3% NaCl and water intake. Neurosci. Lett. 214 (1996) 158
8. Eglen R.M., Hudson A.L., Kendall D.A., Nutt D.J., Morgan N.G., Wilson V.G., and Dillon M.P. 'Seeing through a glass darkly': casting light on imidazoline 'I' sites. Trends Pharmacol. Sci. 19 (1998) 381-390
9. El-Ayoubi R., Menaouar A., Gutkowska J., and Mukaddam-Daher S. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist. Br. J. Pharmacol. 145 (2005) 50-56
10. 1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J. Hypertens., Suppl. 1 (1997) S9-23
11. Ferrari A.C., Camargo L.A.A., Saad W.A., Renzi A., De Luca Jr. L.A., and Menani J.V. Clonidine and phenylephrine injected into the lateral hypothalamus inhibit water intake in rats. Brain Res. 522 (1990) 125-130
12. Fregly M.J., Kelleher D.L., and Greenleaf J.E. Antidipsogenic effect of clonidine on angiotensin II-, hypertonic saline-, pilocarpine- and dehydration-induced water intake. Brain Res. Bull. 7 (1981) 661-664
13. Fregly M.J., Rowland N., and Greenleaf J.E. A role for presynaptic α2-adrenoceptors in angiotensin II-induced drinking in rats. Brain Res. Bull. 12 (1984) 393-398
14. Fregly M.J., Rowland N., and Greenleaf J.E. Clonidine antagonism of angiotensin-related drinking: a central site of action. Brain Res. 298 (1984) 321-327
15. 2 sites in the mammalian central nervous system. Pharm. Ther. 68 (1995) 175-208
16. Guyenet P.G. Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites?. Am. J. Physiol. 273 (1997) R1580-R1584
17. Haxhiu M.A., Dreshaj I., Schafer S.G., and Ensberger P. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla. J. Cardiovasc. Pharmacol. 24 (1994) S1-S8
18. Hohage H., Mehrens T., Matzkies F., Steinmetz M., and Greven J. Effects of moxonidine and clonidine on potassium excretion in Sprague-Dawley rats. Pharmacol. Res. 39 (1999) 357-361
19. 3H]rilmenidine. Brain Res. 675 (1995) 264-278
20. Le Douarec J.C., Schmitt H., and Lucet B. Influence de la clonidine et des substances alfa-sympathomimetiques sur la prise d'eau chez le rat assoiffe. J. Pharmacol. (Paris) 2 (1971) 435-444
21. Menani J.V., Sato M.A., Haikel L., Vieira A.A., Andrade C.A.F., Silva D.C.F., Renzi A., and De Luca Jr. L.A. Central moxonidine on water and NaCl intake. Brain Res. Bull. 49 (1999) 273-279
22. 2-adrenergic/imidazoline receptors in the control of thirst, sodium appetite and renal excretion. In: Chen F.J. (Ed). New Trends in Brain Research (2006), Nova Science Publishers, Inc. 95-126
23. Moreira T.S., Takakura A.C.T., Menani J.V., Sato M.A., and Colombari E. Central blockade of nitric oxide synthesis reduces moxonidine-induced hypotension. Br. J. Pharmacol. 142 (2004) 765-771
24. Moreira T.S., Takakura A.C.T., Menani J., and Colombari E. Involvement of central alpha(1)- and alpha(2)-adrenoceptors on cardiovascular responses to moxonidine. Eur. J. Pharmacol. 563 (2007) 164-171
25. Mukaddam-Daher S., and Gutkowska J. Atrial natriuretic peptide is involved in renal actions of moxonidine. Hypertension 35 (2000) 1215-1220
26. Nurminen M.L., Culman J., Haass M., Chung O., and Unger T. Effect of moxonidine on blood pressure and sympathetic tone in conscious spontaneously hypertensive rats. Eur. J. Pharmacol. 362 (1998) 61-67
27. Penner S.B., and Smyth D.D. Central and renal I1-imidazoline preferring receptors: two unique sites mediating natriuresis in the rat. Cardiovasc. Drug Ther. 8 (1994) 43-48
28. Penner S.B., and Smyth D.D. Sodium excretion following central administration of an I1 imidazoline receptor agonist, moxonidine. Br. J. Pharmacol. 112 (1994) 1089-1094
29. Penner S.B., and Smyth D.D. Rilmenidine alters renal function when administered intracerebroventricularly or intrarenally. Ann. N. Y. Acad. Sci. 763 (1995) 353-356
30. Penner S.B., and Smyth D.D. The role of the peripheral sympathetic nervous system in the natriuresis following central administration of an I1 imidazoline agonist, moxonidine. Br. J. Pharmacol. 116 (1995) 2631-2636
31. Ruggiero D.A., Regunathan S., Wang H., Milner T.A., and Reis D.J. Immunocytochemical localization of an imidazoline receptor protein in the central nervous system. Brain Res. 780 (1998) 270-293
32. Smyth D.D., and Penner S.B. Imidazoline receptor mediated natriuresis: central and/or peripheral effect?. J. Auton. Nerv. Syst. 72 (1998) 155-162
33. Smyth D.D., and Penner S.B. Peripheral and central imidazoline receptor-mediated natriuresis in the rat. Ann. N. Y. Acad. Sci. 881 (1999) 344-357